<DOC>
	<DOCNO>NCT00551629</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability immunogenicity 4 different formulation HR5I vaccine ( Haemophilus influenzae type b conjugate , recombinant hepatitis B surface antigen , diphtheria , tetanus , 5-component acellular pertussis , inactivate poliovirus Types 1 , 2 , 3 ) . The primary hypothesis least 1 4 formulation HR5I administer primary series 2 , 3 , 4 month age acceptable ( similar target rate ) respect Postdose 3 antibody response antigen .</brief_summary>
	<brief_title>A Study Test Safety Effectiveness Investigational Vaccine Infants ( V419-002 )</brief_title>
	<detailed_description>Participants randomize 4 arm : AR51 ( 12 , 10 ) : arm receiving vaccine formulation contain 12 mcg polyribosylribitol phosphate ( PRP ) conjugate tetanus toxoid ( PRP-T ) 10 mcg Hepatitis B surface antigen ( HBsAg ) PR51 ( 3 , 10 ) : arm receiving vaccine formulation contain 3 mcg PRP conjugate outer membrane protein complex Neisseria meningitides ( PRP-OMPC ) 10 mcg HBsAg PR51 ( 6 , 10 ) : arm receiving vaccine formulation contain 6 mcg PRP-OMPC 10 mcg HBsAg PR51 ( 6 , 15 ) : arm receiving vaccine formulation contain 6 mcg PRP-OMPC 15 mcg HBsAg</detailed_description>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy infant 2 month age receive prior vaccination Haemophilus influenzae type b ( Hib ) , hepatitis B , Diptheria/Pertussis/Tetanus ( DPT ) , Polio Exclusion Criteria : Documented HIV infection ( child mother ) Documented HBsAgseropositivity ( child mother ) History invasive Hib disease , hepatitis B , diphtheria , tetanus , pertussis , poliovirus infection History seizure disorder , developmental delay , neurologic disorder Underlying medical condition inborn error metabolism , failure thrive , major congenital abnormality require surgery Prior anticipate receipt immune globulin , blood , blood product Known hypersensitivity component investigational vaccine administer protocol Any history condition would exclude child receive vaccine administer protocol Any condition , opinion investigator , may interfere evaluation study objective</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>9 Weeks</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>